Quipt Home Medical Corp (QIPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,703 | -5,563 | -5,429 | N/A | N/A |
| Depreciation Amortization | 14,538 | 10,805 | 12,103 | N/A | N/A |
| Accounts receivable | -5,115 | -5,146 | -7,047 | N/A | N/A |
| Other Working Capital | -4,619 | -3,811 | -2,035 | N/A | N/A |
| Other Operating Activity | 12,933 | 12,081 | 13,124 | 0 | 0 |
| Operating Cash Flow | $14,034 | $8,366 | $10,716 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 162 | -1,197 | -225 | N/A | N/A |
| Net Acquisitions | -8,015 | 2,959 | -425 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -78 | 0 | 0 |
| Investing Cash Flow | $-7,853 | $1,762 | $-729 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,008 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 11,298 | N/A | N/A | N/A |
| Debt Repayment | -12,970 | -6,496 | N/A | N/A | N/A |
| Common Stock Issued | 21,254 | 3,154 | 196 | N/A | N/A |
| Other Financing Activity | -571 | -11,767 | -10,780 | 0 | 0 |
| Financing Cash Flow | $13,721 | $-3,811 | $-10,583 | $N/A | $N/A |
| Exchange Rate Effect | -383 | 104 | 1,328 | N/A | N/A |
| Beginning Cash Position | 9,708 | 3,262 | 2,642 | N/A | N/A |
| End Cash Position | 29,227 | 9,682 | 3,375 | N/A | N/A |
| Net Cash Flow | $19,519 | $6,420 | $732 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,034 | 8,366 | 10,716 | N/A | N/A |
| Capital Expenditure | -91 | -1,358 | -534 | N/A | N/A |
| Free Cash Flow | 13,943 | 7,008 | 10,183 | 0 | 0 |